Quantcast

Posts related to ‘TASR’

Top 10 Pre-Market Analyst Calls (CPLA, CEPH, DYN, HBC, MS, SGP, SLM, TASR, TROW, VISN)

Below are the top analyst calls that 247WallSt.com is looking at this morning:Capella Education (NASDAQ: CPLA) started as Neutral at JPMorgan.Cephalon (NASDAQ: CEPH) raised to Strong Buy at Broadpoint.Dynegy (NYSE: ...
Read Full Story »

Top Pre-Market Stock News (January 7, 2008)

Below is a snapshot of some of the key impact news affecting stocks in pre-market trading this Monday, January 7, 2008:AllianceBernstein (AB) noted as a hidden gem in Barron's cover ...
Read Full Story »

Pre-Market Stock News (November 14, 2007)

Below is some of the top news pre-market:Applied Materials (AMAT) reports earnings after close; estimates are $0.29 EPS & R$2.38B.BEA Systems (BEAS) said it expects to submit SEC filings tomorrow ...
Read Full Story »

Early Research Calls 8/20/2007

Merriman upgrades Taser (TASR) from neutral to buy.Lehman (LEH) upgrades Motorola (MOT) from equal weight to overweight.Sun Trust starts Penn Virginia with a buy and $54 price target.Cowen upgrades Lab ...
Read Full Story »

TASER & iRobot: Creating the Terminator? (TASR, IRBT)

TASER International, Inc. (TASR-NASDAQ) has announced a strategic alliance with iRobot Corp. (IRBT-NASDAQ) to develop a new robotic capability utilizing TASER(r) technologies. This combination of capabilities is intended to allow ...
Read Full Story »

Pre-Market Stock News (June 28, 2007)

(AAPL) Apple’s iPhone launches tomorrow.(ABPI) Accentia Biopharma announced favorable interim blinded data on SinuNase in its fast-tracked pivotal Phase III clinical trial.(ALVR) Alvarion in pact with Australian government over a ...
Read Full Story »

Pre-Market Stock News (June 27, 2007)

(ANDW) Andrew Corp being acquired for $15.00 per share.(APOG) Apogee Enterprises $0.34 EPS vs $0.23e; unsure if comparable.(AUTH) AuthenTec priced its 7.5M share IPO at the top of the $9.00 ...
Read Full Story »

Pre-Market Stock News (June 19, 2007)

(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering integration.(BMY) Bristol-Myers: ...
Read Full Story »

Pre-Market Stock News (June 14, 2007)

(APPAD) AP Pharmaceuticals announces the pricing of its underwritten public offering of 21.2 million shares of its common stock at a public offering price of $1.65 per share.(BBND) Bigband Networks ...
Read Full Story »